Predictive Elements of Trauma and Its After-effects: Importance of the Quality of Neurobiological Response to Stress
NCT ID: NCT04530214
Last Updated: 2023-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
130 participants
OBSERVATIONAL
2020-11-04
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is based on the hypothesis that a severe physical or psychological trauma is associated with an intense and misfitted stress that is responsible from an undue immuno-inflammatory activation (through sympathetic activation). The result is a subinvasive state of systemic and tissue inflammation (low-noise inflammation), responsible for the mid-term deleterious consequences of the traumatic event.
The objective of this study is to understand how the dysregulation of intense stress simultaneously generates an initial pathological state and an alteration of mid-term evolution (which is considered as a poor prognosis and/or as responsible for after-effects).
The investigators wish to identify relevant biomarkers of the mechanisms activated during intense stress and influencing the immuno-inflammatory and epigenetic spheres with deleterious consequences on physiological and psychological functions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Factors of PTSD in Adults Admitted to an Emergency Service
NCT03615014
Stressor-evoked Brain and Cardiovascular Responses to Acute Psychological Stress
NCT05413512
Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST
NCT00451126
Neurofeedback Prevention For Early Stress Related Adversity
NCT02477722
Post Traumatic Stress Disorder and Neural Mechanisms Involved in Its Treatment
NCT00893568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood collection
Blood collection at enrollment (before surgery) and at Visit 1 (45-60 days following surgery)
Saliva collection
Saliva collection at enrollment (before surgery) and at Visit 1 (45-60 days following surgery)
Electrocardiography (ECG)
Electrocardiography (ECG) at enrollment (24-72h following surgery) and at Visit 1 (45-60 days following surgery) to assess heart rate variability
Questionnaires
Mental health assessment through questionnaires at enrollment (24-72h following surgery), at Visit 1 (45-60 days following surgery), at Visit 2 (7 months following surgery) and at Visit 3 (12 months following surgery)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitive state allowing the understanding of questionnaires
Exclusion Criteria
* Chronic inflammatory or immune pathologies
* On anticoagulants
* On neuroleptic or antidepressant treatment
* Pathology or health condition not allowing 1-year survival
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Pellegrin
Bordeaux, , France
Hôpital d'Instruction des Armées Percy
Clamart, , France
Hôpital d'Instruction des Armées Bégin
Saint-Mandé, , France
Hôpital d'Instruction des Armées Sainte-Anne
Toulon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Cédric GIL-JARDINE, MD
Role: primary
Sylvain MARTINEZ, MD
Role: primary
Diane COMMANDEUR, MD
Role: primary
Julien BORDES, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01811-56
Identifier Type: OTHER
Identifier Source: secondary_id
2018PPRC30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.